Ferritiva develops technology for rapid, noninvasive measurement of iron levels in the body. This diagnostic approach eliminates the need for traditional blood draws associated with standard iron panel testing. The company provides clinicians with immediate, accessible data for efficient anemia and iron deficiency management.
Funding
$150K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
CNFounders
Product
Problem
Current methods for monitoring iron levels often require invasive blood draws, specialized equipment, and laboratory analysis, creating inconvenience and limiting accessibility for frequent or at-home testing. This can lead to delayed detection and management of iron deficiency, particularly for individuals requiring regular monitoring.
Solution
Ferritiva is developing a non-invasive diagnostic device that allows individuals to monitor their iron levels through saliva samples. This technology offers a convenient and cost-effective alternative to traditional blood tests, enabling users to track their iron status from the comfort of their homes. The device aims to provide timely insights into iron deficiency, empowering individuals to make informed decisions about their health and seek appropriate medical advice when necessary. By eliminating the need for phlebotomy and laboratory processing, Ferritiva seeks to improve access to iron-level monitoring for a wider range of users.
Target Audience
The primary target audience includes athletes, pregnant women, individuals with chronic conditions, and anyone requiring regular monitoring of their iron levels.
Features
- Non-invasive iron level monitoring using saliva samples
- Point-of-care testing without the need for specialized equipment or trained personnel
- Rapid results for timely insights into iron status
- User-friendly design for easy at-home use